Intuitive Surgical, Inc. (VIE:ISRG)
Austria · Delayed Price · Currency is EUR | Market Cap | 124.55B -24.0% |
| Revenue (ttm) | 9.66B +20.7% |
| Net Income | 2.75B +20.4% |
| EPS | 7.63 +21.6% |
| Shares Out | n/a |
| PE Ratio | 45.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 339.70 |
| Previous Close | 341.95 |
| Day's Range | 339.70 - 350.10 |
| 52-Week Range | 333.55 - 515.40 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 16, 2026 |
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,... [Read more]
Financial Performance
In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.
Financial numbers in USD Financial StatementsNews
Intuitive Surgical beats quarterly estimates on strong demand for its robotic systems
Intuitive Surgical on Thursday maintained its 2026 forecast for worldwide growth in procedures assisted by its cutting-edge da Vinci robots, after beating Wall Street estimates for second-quarter pr...
Intuitive Surgical says environment in China remains challenging
Says growth in the U.S. moderated from recent trends and expectations at the start of the year. Says some have said that changes in patient coverage and premium dynamics may…
Intuitive Surgical Earnings Call Transcript: Q2 2026
Q2 2026 delivered 19% revenue growth, strong global adoption of da Vinci and Ion platforms, and robust capital placements. Guidance for 2026 procedure growth and margins was maintained or raised, with continued innovation and expansion in key markets despite challenges in China and Europe.
Intuitive Surgical Earnings release: Q2 2026
Intuitive Surgical released its Q2 2026 earnings on July 16, 2026, summarizing the period's financial results.
Intuitive Surgical backs FY26 da Vinci procedure growth view 13.5%-15.5%
Raises FY26 gross profit margin view to 68%-69% of revenue from 67.5%-68.5% of revenue. Narrows FY26 operating expense growth view to 11%-13% from 11%-14%. The company said, “The range for…
Intuitive Surgical reports Q2 EPS $2.80, consensus $2.50
Reports Q2 revenue $2.89B, consensus $2.83B. Worldwide procedures grew approximately 16% compared with the second quarter of 2025. The company placed 468 da Vinci surgical systems, compared with 395 i...
Intuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...
Intuitive Surgical price target lowered to $510 from $580 at Truist
Truist lowered the firm’s price target on Intuitive Surgical (ISRG) to $510 from $580 and keeps a Buy rating on the shares as part of a broader research note previewing…
Intuitive Surgical price target lowered to $500 from $525 at Mizuho
Mizuho lowered the firm’s price target on Intuitive Surgical (ISRG) to $500 from $525 and keeps a Neutral rating on the shares. The firm adjusted targets in the medical device…
Intuitive Surgical price target lowered to $600 from $650 at RBC Capital
RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $600 from $650 and keeps an Outperform rating on the shares as part of a broader research note…
Intuitive Surgical price target lowered to $520 from $585 at TD Cowen
TD Cowen lowered the firm’s price target on Intuitive Surgical (ISRG) to $520 from $585 and keeps a Buy rating on the shares. The firm said the company continues to…
Intuitive Surgical price target lowered to $512 from $574 at BTIG
BTIG lowered the firm’s price target on Intuitive Surgical (ISRG) to $512 from $574 and keeps a Buy rating on the shares as part of a broader research note previewing…
BMO starts Intuitive Surgical initiated with an Outperform on durable earnings
As previously reported, BMO Capital analyst Vik Chopra initiated coverage of Intuitive Surgical (ISRG) with an Outperform rating and $518 price target The da Vinci 5 upgrade cycle is still…
Intuitive Surgical initiated with an Outperform at BMO Capital
BMO Capital initiated coverage of Intuitive Surgical (ISRG) with an Outperform rating and $518 price target
Citi adds ‘upside 90-day catalyst watch’ on Intuitive Surgical
Citi is adding an “upside 90-day catalyst watch” on Intuitive Surgical (ISRG) while keeping a Buy rating and $590 price target on shares. Shares have been pressured year-to-date by concerns…
Intuitive Surgical price target lowered to $430 from $480 at Evercore ISI
Evercore ISI lowered the firm’s price target on Intuitive Surgical (ISRG) to $430 from $480 and keeps an In Line rating on the shares. The firm’s Q2 preview for MedTech,…
Robotics Then & Now: 2000 to 2026 by the Numbers
In 2000, a “robot” mostly meant a caged arm bolted to a car line, repeating one welded seam. Most could not see, none could leave their cells unsupervised, and a full installation ran into six figures...
Intuitive Surgical price target lowered to $515 from $520 at BofA
BofA analyst Travis Steed lowered the firm’s price target on Intuitive Surgical (ISRG) to $515 from $520 and keeps a Buy rating on the shares. Noting that the firm’s services…
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business...
Intuitive Announces Innovations to Advance Quintuple Aim
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security Latest innovations ...
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) a...
Intuitive Surgical Transcript: AGM 2026
The meeting saw all board nominees elected and all proposals approved, including executive compensation and auditor ratification. Strong financial results were reported for 2025 and Q1 2026, with continued focus on global expansion, innovation, and manufacturing optimization amid competitive and geopolitical challenges.
The Biggest Takeaway From ISRG Earnings
The key takeaway from Intuitive Surgical's (ISRG) Q1 2026 results is the implementation of a fundamental “Platform Refresh Wall.” In addition to the $2.50 EPS exceeding expectations and a revenue grow...
Intuitive Surgical beats quarterly expectations on surgical robot demand
Intuitive Surgical on Tuesday beat Wall Street estimates for first-quarter profit and revenue, as the firm rode the wave of robust demand for its minimally invasive surgical robots used in complex m...
Intuitive Announces First Quarter Earnings
SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today...